Tech Company Financing Transactions
Trinity Biosystems Funding Round
On 6/30/2006, Trinity Biosystems secured $21 million in funding from Amgen Ventures, Sanderling Ventures and SR One Capital Management.
Transaction Overview
Company Name
Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1490 O'Brien Drive A
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Trinity Biosystems, Inc., is developing a unique platform technology to produce a new class of vaccines and enable the oral delivery of proteins and other peptides.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Peter McWilliams
Chief Scientific Officer
Amin Khan
Founder
Randall Mrsny
Browse more venture capital transactions:
Prev: 6/30/2006: Visionsense venture capital transaction
Next: 6/30/2006: Voyence venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs